Icon reports more expectation-beating results

This article was originally published here

Medtech, pharma and biotech development outsourcer Icon continues to beat the Street when it comes to its results.

Dublin, Ireland–based Icon (Nasdaq:ICLR) said today that it earned $78.5 million, or $1.43 per share, off $455.1 million in sales for the fourth quarter ended Dec. 31, 2017 – up from $74.3 million, or $1.33 per share, in profits off $435.1 million in revenue for the same quarter a year before.

Analysts on average had expected fourth-quarter profits of $1.42 per share off $454.6 million in revenue, according to Yahoo Finance.

Get the full story on our sister site Medical Design & Outsourcing.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply